In some countries, this medicine may only be approved for veterinary use.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
H01AA02
CAS registry number (Chemical Abstracts Service)
0016960-16-0
Chemical Formula
C136-H210-N40-O31-S
Molecular Weight
2933
Therapeutic Category
Analogue of adrenocorticotropic hormone (ACTH)
Chemical Name
α1-24-Corticotropin
Foreign Names
- Tetracosactidum (Latin)
- Tetracosactid (German)
- Tétracosactide (French)
- Tetracosactida (Spanish)
Generic Names
- Cosyntropin (OS: USAN)
- Tetracosactide (OS: BAN, DCIT)
- Tétracosactide (OS: DCF)
- Ciba 30920 Ba (IS: Ciba)
- Tetracosactrin (IS)
- Tetracosactid (PH: Ph. Eur. 6)
- Tetracosactide (PH: BP 2010, Ph. Eur. 6)
- Tétracosactide (PH: Ph. Eur. 6)
- Tetracosactidum (PH: Ph. Eur. 6)
- Tetracosactide Acetate (OS: BANM)
- Tetracosactidi hexaacetas (IS)
- Tetracosactrin Acetate (IS)
- Tetracosactrin Zinc Injection (PH: BP 1999)
Brand Names
- Cortrosyn
Amphastar, Canada; Organon, Tunisia - Cosyntropin
Sandoz, United States - Cosyntropin (pediatric)
Generamedix, United States - Synacthen
Novartis, Chile; Novartis, Luxembourg; Novartis, Turkey - Synacthen Depot
Defiante, Austria; Novartis, Romania - Synacthène Retard
Novartis, Tunisia - Synacthène
Novartis, France - Cortrosyn Depot
Organon, United Arab Emirates; Organon, Bahrain; Organon, Cyprus; Organon, Egypt; Organon, Iraq; Organon, Iran; Organon, Jordan; Organon, Kuwait; Organon, Lebanon; Organon, Libya; Organon, Qatar; Organon, Saudi Arabia; Organon, Sudan; Organon, Syria; Organon, Yemen - Cortrosyn Z
Daiichi Sankyo, Japan - Cortrosyn
Daiichi Sankyo, Japan; Organon, Hong Kong - Nuvacthen
IFET, Greece; Novartis, Spain - Synacthen
Alliance, United Kingdom; Defiante, Austria; Novartis, Australia; Novartis, Belgium; Novartis, Switzerland; Novartis, Denmark; Novartis, Ireland; Novartis, Italy; Novartis, Netherlands; Novartis, New Zealand; Novartis, Portugal; Sigma-tau, Germany; Swedish Orphan, Sweden - Synacthen (veterinary use)
Alliance, United Kingdom - Synacthen Depot
Novartis, Israel; Novartis, New Zealand; Novartis, Oman; Novartis, Portugal; Novartis, Russian Federation; Novartis, South Africa; Swedish Orphan, Sweden - Synacthen
Novartis, Venezuela - Synacthen Depot
Novartis, Australia; Novartis, Canada; Novartis, Ghana; Novartis, Kenya; Novartis, Luxembourg; Novartis, Libya; Novartis, Nigeria; Novartis, Romania; Novartis, Sudan; Novartis, Tanzania; Novartis, Zimbabwe - Synacthène Retard
Novartis, France
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment